Samsung Pharm (001360) — Capital Reinvestment Ratio
Samsung Pharm (001360) has a Capital Reinvestment Ratio of 0.40x as of June 2022, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩638.30 Million). See Samsung Pharm balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Samsung Pharm Capital Reinvestment Ratio (2017–2017)
This chart tracks Samsung Pharm's Capital Reinvestment Ratio across 1 annual periods. Check 001360 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Samsung Pharm (2017–2017)
Year-by-year Capital Reinvestment Ratio for Samsung Pharm from 2017 to 2017. For live market cap and broader valuation context, see Samsung Pharm market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 1.19x | ₩5.15 Billion | ₩6.11 Billion | — |